ClinicalTrials.govpublic full text
Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
hormone sensitive prostate cancer, prostate adenocarcinoma, metastasis prostate adenocarcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 283053
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.